| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
5e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-05 |
| mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |